Trust stops making cancer drugs after criticism from regulator

By Alison Moore2019-11-04T13:01:00

An acute trust is to abandon manufacturing its own radiopharmaceuticals after a regulator said it needed more quality improvement work and better facilities.

You need to be signed in to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All of HSJ.co.uk and our HSJ mobile app
News and insight on all areas of public funded healthcare
Expert commentary, insight and analysis from industry leaders
9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

to HSJ

Sign into your account here